Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
Abstract Background The global pandemic of coronavirus disease 2019 (COVID-19) infection is ongoing and associated with high mortality. The aim of this study was to investigate the efficacy and safety of subcutaneous injection of interferon alpha-2b (IFN alpha-2b) combined with lopinavir/ritonavir (...
Main Authors: | Bo Wang, Diandian Li, Tao Liu, Haohua Wang, Fengming Luo, Yanbin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-020-05425-5 |
Similar Items
-
Subcutaneous Mercury Injection by a Child: A Histopathology Case Report
by: Deepti Sukheeja, et al.
Published: (2014-01-01) -
Clinical Trial of Subcutaneous Steroid Injection in Patients with Migraine Disorder
by: Karim Nikkhah, et al.
Published: (2016-02-01) -
The Effect of Injection Duration of Subcutaneous Enoxaparin Sodium on Pain intensity and Bruising of Injection Site
by: Hossein Rahmani Anaraki, et al.
Published: (2013-04-01) -
Characterization of murine interferon alpha 12 (MuIFN α12): biological activities and gene regulation.
Published: (2005) -
Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
by: Matheus Ghossain Barbosa, et al.
Published: (2021-01-01)